Found in translation: turning mouse mammary biology into clinical benefit

Locations
S104 Cancer Sciences
Category
Medical and Dental Sciences
Date(s)
Tuesday 20th May 2014 (13:00-14:00)
Contact

For further information please contact the seminar host, Dr Clare Davies E: C.C.Davies@bham.ac.uk T:+44(0)121 414 9237 or Pauline Goddard E: P.N.Goddard@bham.ac.uk T:+44(0)121 414 7144

Download
Add to Calendar
Description

Found in translation: turning mouse mammary biology into clinical benefit

Dr Matt Smalley,Cancer Stem Cell Research Institute, Cardiff University.

 

Biography

Dr. Matt Smalley is Deputy Director of the European Cancer Stem Cell Research Institute, Cardiff University. Prior to this, Matt's group was based at the Breakthrough Breast Cancer Research Centre at the ICR, London.

His research group is trying to understand how the combination of different tumour-initiating genetic lesions occurring in different normal stem and progenitor cells in the breast drives breast cancer heterogeneity, predominately through the use of genetically engineered mice. His lab is also  trying to understand how the biological processes occurring in normal stem cells can be re-activated in tumours to drive de novo  production of tumour cells with stem cell-like properties.

Matt has published some excellent seminal (Cell Stem Cell, Dev Cell and Development) and his talk will be great. 

If anyone would like to chat to Matt throughout the day on the Tuesday, then please let me know.

See you there!